To investigate whether THC inhalation increases driving collisions, and to explore the relationship between car crashes and self-assessed driving ability as measured by Visual Analog Scales (VAS) and the Karolinska Sleepiness Scale, 30 male volunteers aged 18-30 years old, with a BMI of 18.5-26.2 Kg/m2, moderate tobacco and caffeine consumption, and at least one year of cannabis use either...
Cannabis use disorder (CUD) is widespread, and there is no pharmacotherapy to facilitate its treatment. AEF0117, the first of a new pharmacological class, is a signaling-specific inhibitor of the cannabinoid receptor 1 (CB1-SSi). AEF0117 selectively inhibits a subset of intracellular effects resulting from Δ9-tetrahydrocannabinol (THC) binding without modifying behavior per se. In mice and...
To study the effect of inhaled cannabis on self-assessed predicted driving ability and its relation to reaction times and driving ability on a driving simulator. 30 healthy male volunteers aged 18-34: 15 chronic (1-2 joints /day) and 15 occasional (1-2 joints/week) consumers. Self-assessed driving confidence (visual analog scale), vigilance (Karolinska), reaction time (mean reciprocal reaction...